11 results
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
also serves on the board of Biotechnology Innovation Organization, a biotechnology trade association, where he serves on its Health Section Governing
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
to be similar to, or interchangeable with, an FDA-licensed reference biological product was created by the Biologics Price Competition and Innovation …
The biopharma industry is characterized by intense competition and rapid innovation. Our potential competitors include large pharmaceutical
10-Q
rb7q32ltpqkk rj
15 Jun 23
Quarterly report
4:19pm
424B4
9ngzkwbj uu5c9ky2b
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
662ri3s8o 2f
1 May 23
IPO registration (amended)
6:10am
S-1
EX-4.2
cf39a gcw
13 Apr 23
IPO registration
5:10pm
S-1
d8guh1fr9p4 axg
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next